Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Esperion Therapeutics
Sort By
Newest First
1 / 1
1 / 1
Funding
Esperion Raises an Additional $200 Million
Nice Insight
PAO-M07-19-NI-015
Jul 10, 2019
Funding
Esperion and Oberland Capital Announce $200 Million Funding Agreement
Oberland Capital
PR-M07-19-NI-007
Jul 03, 2019
Cholesterol
Third PCSK9 Inhibitor for Lowering Cholesterol Moves into Phase III Trials
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-005
Nov 05, 2018
